A major landmark study reveals that global immunization efforts have saved an estimated 154 million lives - or the equivalent of 6 lives every minute of every year - over the past 50 years. The vast majority of lives saved were infants.
High cholesterol is becoming an all-too common health problem. Now a new vaccine currently in development promises to effectively and affordably lower levels of 'bad' cholesterol in the body.
This year’s Nobel Prize in Physiology or Medicine has been awarded to biochemist Katalin Karikó and immunologist Drew Weissman for discoveries that enabled the development of mRNA vaccines against COVID-19.
The drug could protect bees from American foulbrood, a bacteria that can devastate entire colonies.
China became the first country to approve a needle-free, inhaled version of a Covid-19 vaccine. The vaccine is similar to those developed by AstraZeneca Plc and Johnson & Johnson.
Cases of COVID-19 are extremely rare among people who are fully vaccinated, according to a U.S. data analysis. COVID- 19 breakthroughs occur at the rate of less than 0.008 % of fully vaccinated people.
A handful of countries representing just 16 percent of the world's population have snapped up more than half of the available COVID-19 vaccines. If the rich world continues to hoard vaccines, the pandemic will drag on for long.
U.S. firm Moderna said that Phase 3 stage analysis suggested its coronavirus vaccine could prevent COVID-19. The news comes a week after Pfizer and German drug-maker BioNTech announced a vaccine of their own.
Hospital workers who got vaccinated were significantly less likely to develop COVID than those who did not. These findings do not prove that flu vaccines prevent COVID-19, however.
A U.S. scientific team has successfully redesigned a key protein from the coronavirus, and the modification could enable much faster and more stable production of vaccines worldwide.
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted antibody activity.
The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans, according to new research.
U.S biophysicists have used the IBM-built supercomputer SUMMIT to sift through thousands of molecules and find potential compounds that could be used as a new drug against the coronavirus responsible for the current COVID-19 pandemic.
Scientists have discovered immune cells that can fight all known flu viruses in what was hailed as an "extraordinary breakthrough" that could lead to a universal, one-shot vaccine against the killer disease.
Check out these big global health wins from 2018 — they’re just the start of good things to come in the fight to eradicate extreme poverty by 2030.
